WO1998040063A1 - Quaternary salts of 2-hydroxy acids - Google Patents
Quaternary salts of 2-hydroxy acids Download PDFInfo
- Publication number
- WO1998040063A1 WO1998040063A1 PCT/US1998/004969 US9804969W WO9840063A1 WO 1998040063 A1 WO1998040063 A1 WO 1998040063A1 US 9804969 W US9804969 W US 9804969W WO 9840063 A1 WO9840063 A1 WO 9840063A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- salt
- acid
- quaternary
- triethanolamine
- diethanolamine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/01—Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/01—Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups
- C07C59/06—Glycolic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/01—Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups
- C07C59/08—Lactic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/75—Anti-irritant
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Emergency Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Cosmetics (AREA)
Abstract
Quaternary salts of 2-hydroxy acids with an alkanolamine such as monoethanolamine, diethanolamine or triethanolamine are useful for incorporation in skin and cosmetic formulations. The acid may contain 2 to 24 carbon atoms, preferably 2 to 17 carbon atoms. The monoethanolamine, diethanolamine and triethanolamine salts of 2-hydroxy acids such as glycolic, lactic, 2-hydroxydecanoic, 2-hydroxyoctanoic and 2-hydroxylauric acid are quite water-soluble and cosmetic formulations containing such salts are non-irritating to the skin.
Description
QUATERNARY SALTS OF 2-HYDROXY ACIDS
Background of the Invention
Alpha-hydroxy acids (i.e. 2-hydroxy acids) are known in the prior art. Such acids are used extensively in cosmetic formulations. However, there are a number of disadvantages associated with the use of such acids in cosmetic formulations. In particular, such acids are generally insoluble in water or other non-toxic solvents. Moreover, these acids can be highly corrosive effect to the skin.
Objects of the Invention
It is an object of the invention to provide 2-hydroxy acid compositions which will be highly soluble in water and other non-toxic solvents commonly used in cosmetic formulations (e.g. 1,3-butylene glycol).
It is a further object of the invention to provide 2-hydroxy acid compositions which will be less irritating to the skin than prior art 2-hydroxy acids when incorporated into cosmetic formulations.
Details of the Invention The objects of the invention have been met by providing novel quaternary salts of 2-hydroxy acids. Such salts will be the quaternary salts of the 2-hydroxy acids with an alkanolamine which may be monoethanolamine, diethanolamine or triethanolamine .
The quaternary salts of the 2-hydroxy acids will have a formula selected from the group consisting of:
+ R-CH( OH ) -COO- NH3CH2CH2OH
+ R-CH ( OH ) -COO- NH2 ( CH2CH2OH ) 2 and
+ R-CH ( OH ) -COO- NH( CH2CH2OH ) 3
wherein R is hydrogen or a Cj-C22 , preferably C3-C15 , alkyl group .
The 2-hydroxy acid will generally be one which has 2 to about 24, preferably 2 to 17, carbon atoms. Preferable examples of such 2-hydroxy acids include glycolic acid, lactic acid, 2-hydroxydecanoic acid, 2-hydroxyoctanoic acid and 2-hydroxylauric acid.
The 2-hydroxy acid quaternary salts of the invention may be readily prepared as follows:
(a) dissolve the selected 2-hydroxy acid in a non-reactive solvent; (b) add an alkanolamine selected from the group consisting of monoethanolamine, diethanolamine and triethanolamine to the solution resulting from step (a); and (c) recover the quaternary salt from the reaction mixture resulting from step (b) or utilize the quaternary salt in the form of a solution without recovery thereof.
In step (a), the choice of solvent is not critical so long as it is one which is non-reactive with the selected 2-hydroxy acid or the selected alkanolamine. Thus the solvent may be non-polar in nature such as methylene chloride, ethyl acetate, n-hexane, n-heptane and the like; alternatively, the solvent may be polar in nature such as water or a non-toxic solvent such as isopropanol, 1,3-butylene glycol, isocetyl alcohol, etc. Preferably, the non-reactive solvent is non- polar in nature such as methylene chloride. Typically, 15 to 30 parts by weight of the selected 2-hydroxy acid will be utilized per 100 parts by weight of the selected non-polar solvent. Step (a) is conveniently carried out at temperatures of about 15 to 50°C.
In step (b), the selected alkanolamine is added, with stirring, to the solution of the 2-hydroxy acid. Generally, the alkanolamine will be utilized in an amount corresponding to the stoichiometric amount required for the selected 2-hydroxγ acid. Step (b) is also conveniently carried out at temperatures of about 15 to 50°C. The reaction between the 2-hydroxy acid and the alkanolamine proceeds fairly
quickly and is exothermic in nature. Therefore, cooling the reaction mixture to a temperature of about 25 to 35 °C and adding the alkanolamine slowly, e.g. over a period of time of about 0.5 to 1 hour, is desirable.
In step (c), the quaternary salt will precipitate out if the selected solvent was non-polar in nature and is readily recovered by filtration. Typically, the salt will be washed with non-polar solvents such as methylene chloride and/or n-heptane to remove any unreacted components and thereafter dried (in air and/or vacuum-dried at temperatures of about 40 to 70°C). Alternatively, if the selected solvent was a non- toxic polar solvent and it is desired to manufacture a solvent solution of the quaternary salt, the salt need not be recovered from the reaction mixture.
Typically, the yield of the quaternary salt will be nearly quantitative, e.g. 80-98% of theory. The quaternary salts of the 2-hydroxy acids of the invention will typically have a water solubility of about 15 to 30 wt.%.
The following examples shall serve to illustrate the invention. Unless otherwise indicated, all parts and percentages are on a weight basis.
Example 1
A 3-liter, 3-neck flask was equipped with a stirrer, thermometer, condenser, addition funnel and a heating/cooling bath. 282 g (1.5 m) of 2-hydroxydecanoic acid were placed in the flask together with 1.5 kg of methylene chloride. Stirring was commenced and the temperature was adjusted to 30°C. 223.8 g (1.5 m) of triethanolamine was added, while stirring the reaction mixture, over a period of 1 hour, while the temperature of the reaction mixture was maintained in the range of 27 to 33°C by external cooling.
The reaction mixture was stirred for an additional two hours, while maintaining the temperature at 35 °C. The reaction
mixture was then cooled to 20"C and the precipitate was collected by filtration. The product (i.e. the precipitate) was washed with 500 g methylene chloride and thereafter washed with 300 g of n-heptane. The product was air-dried for several hours and thereafter dried under vacuum at 50- 60"C for 4 hours. The product yield was 481 g (95% of theory). The product was soluble in water in excess of 20 wt.%.
Example 2 Example 1 was repeated using 188 g (1.0 m) of 2-hydroxy- decanoic acid, 940 g methylene chloride and 105 g (1.0 m) of diethanolamine. After working up the product in the same manner, 273 g of product (93.2% of theory) was obtained. The product was soluble in water in excess of 20 wt.%.
Example 3
Example 1 was repeated using 160 g (1.0 m) 2-hydroxyoctanoic acid, 1.0 kg methylene chloride and 149.2 g (1.0 ) of triethanolamine. After working up the product in the same manner, 290 g of product (94% of theory) was obtained. The product was soluble in water in excess of 20 wt.%.
Example 4
Example 3 was repeated using 105 g (1.0 m) of diethanolamine instead of the triethanolamine. 236 g (89% of theory) of product was obtained. The product was soluble in water in excess of 20 wt.%.
Example 5
Example 1 was repeated using a 1-liter, 3-neck flask. 25.33 g (0.33 m) of glycolic acid was dissolved in 200 ml ethyl acetate at a temperature of 35-45 °C. Thereafter, 49.7 g (0.33 m) of triethanolamine was added over a period of one hour and stirring was continued for 2 hours at 40°C. 69 g (92% of theory) of product having a solubility in water in excess of 20 wt.% were obtained.
Example 6
Example 1 was repeated using 212 g (1.0 m) of 2-hydroxylauric acid, 1.5 kg methylene chloride and 149.2 g (1.0 m) triethanolamine). 346 g (95.8% of theory) of product having a solubility in water in excess of 20 wt.% were obtained.
Example 7
Example 6 was repeated using 105 g (1.0 m) of diethanolamine instead of the triethanolamine. 346 g (95.8% of theory) of product having a solubility in water in excess of 20 wt.% were obtained.
Example 8
Example 1 was repeated using a 1-liter, 3-neck flask. 29.5 g of 85% d-1 lactic acid (0.28 m) was dissolved in 150 g of isopropanol at a temperature of 35-45 °C. Thereafter, 41.7 g (0.28 m) of triethanolamine was added over a period of one hour and stirring was continued for 2 hours at 35 βC. The reaction mixture was cooled to 5°C and the product was filtered and washed with isopropanol and thereafter vacuum-dried. 56 g (84% of theory) of product having a solubility in water in excess of 20 wt.% were obtained.
Example 9
Example 3 was repeated using 100 g (0.625 m) 2-hydroxγ- octanoic acid, 550 g methylene chloride and 38.2 g (0.625 m) of monoethanolamine. After working up the product in the same manner, 121 g of product (87.6% of theory) was obtained. The product was soluble in water in excess of 20 wt.%.
Claims
1. A quaternary salt of a 2-hydroxy acid having the formula selected from the group consisting of:
+ R-CH(OH)-COO- NH 3,C«--Hπ2,Cι_Hr-,2O.H
R-CH(OH)-COO- NH 2,((CCHHCCHH,2O(_»Hπ) 2, and
+ R-CH(OH)-COO- NH(CH2CH2OH)3
wherein R is hydrogen or a C C22 alkyl group.
2. The salt of claim 1 wherein R is hydrogen.
3. The salt of claim 1 wherein R is a C3-C15 alkyl group.
4. The salt of claim 1 wherein the 2-hydroxy acid is selected from the group consisting of glycolic acid, lactic acid, 2-hydroxydecanoic acid, 2-h╬│droxyoctanoic acid and 2-hydroxylauric acid, and the alkanolamine is selected from the group consisting of monoethanolamine, diethanolamine and triethanolamine.
5. The salt of claim 1 comprising the quaternary salt of glycolic acid with monoethanolamine.
6. The salt of claim 1 comprising the quaternary salt of glycolic acid with diethanolamine.
7. The salt of claim 1 comprising the quaternary salt of glycolic acid with triethanolamine.
8. The salt of claim 1 comprising the quaternary salt of lactic acid with monoethanolamine.
9. The salt of claim 1 comprising the quaternary salt of lactic acid with diethanolamine.
10. The salt of claim 1 comprising the quaternary salt of lactic acid with triethanolamine.
11. The salt of claim 1 comprising the quaternary salt of 2-h╬│droxydecanoic acid with monoethanolamine.
12. The salt of claim 1 comprising the quaternary salt of 2-hydroxydecanoic acid with diethanolamine.
13. The salt of claim 1 comprising the quaternary salt of 2-hydroxydecanoic acid with triethanolamine.
14. The salt of claim 1 comprising the quaternary salt of 2-hydroxyoctanoic acid with monoethanolamine.
15. The salt of claim 1 comprising the quaternary salt of 2-hydroxyoctanoic acid with diethanolamine.
16. The salt of claim 1 comprising the quaternary salt of 2-hydroxyoctanoic acid with triethanolamine.
17. The salt of claim 1 comprising the quaternary salt of 2-hydroxylauric acid with monoethanolamine.
18. The salt of claim 1 comprising the quaternary salt of 2-hydroxylauric acid with diethanolamine.
19. The salt of claim 1 comprising the quaternary salt of 2-hydroxylauric acid with triethanolamine.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US81876697A | 1997-03-14 | 1997-03-14 | |
US08/818,766 | 1997-03-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1998040063A1 true WO1998040063A1 (en) | 1998-09-17 |
Family
ID=25226348
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1998/004969 WO1998040063A1 (en) | 1997-03-14 | 1998-03-13 | Quaternary salts of 2-hydroxy acids |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO1998040063A1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1219288A2 (en) * | 2000-12-21 | 2002-07-03 | Johnson & Johnson Consumer Companies, Inc. | Treatment for skin |
GB2372743A (en) * | 2000-12-20 | 2002-09-04 | Teklube Ltd | Non-toxic bioresistant lactic acid amides and preparation thereof |
US7396526B1 (en) | 1998-11-12 | 2008-07-08 | Johnson & Johnson Consumer Companies, Inc. | Skin care composition |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4105782A (en) * | 1975-03-07 | 1978-08-08 | Yu Ruey J | Treatment of acne and dandruff |
US4363815A (en) * | 1975-07-23 | 1982-12-14 | Yu Ruey J | Alpha hydroxyacids, alpha ketoacids and their use in treating skin conditions |
-
1998
- 1998-03-13 WO PCT/US1998/004969 patent/WO1998040063A1/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4105782A (en) * | 1975-03-07 | 1978-08-08 | Yu Ruey J | Treatment of acne and dandruff |
US4363815A (en) * | 1975-07-23 | 1982-12-14 | Yu Ruey J | Alpha hydroxyacids, alpha ketoacids and their use in treating skin conditions |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7396526B1 (en) | 1998-11-12 | 2008-07-08 | Johnson & Johnson Consumer Companies, Inc. | Skin care composition |
GB2372743A (en) * | 2000-12-20 | 2002-09-04 | Teklube Ltd | Non-toxic bioresistant lactic acid amides and preparation thereof |
GB2372743B (en) * | 2000-12-20 | 2004-03-10 | Teklube Ltd | Aqueous metal-working fluid containing a lactamide, and process for producing alactamide for use in such fluid |
EP1219288A2 (en) * | 2000-12-21 | 2002-07-03 | Johnson & Johnson Consumer Companies, Inc. | Treatment for skin |
EP1219288A3 (en) * | 2000-12-21 | 2003-07-30 | Johnson & Johnson Consumer Companies, Inc. | Treatment for skin |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW336226B (en) | Use of not easily volatilised pyrazol derivatives with hydrophilic groups as nitrification inhibitors | |
IE46471B1 (en) | Novel oxime derivatives and their preparation | |
JPH10226674A (en) | Quasi-ceramide compound, its production and cosmetic composition containing the same | |
JP3522817B2 (en) | Taurine derivative, method for producing the same, detergent composition containing the compound, and intermediate thereof | |
WO1998040063A1 (en) | Quaternary salts of 2-hydroxy acids | |
EP0331556A2 (en) | Process for the preparation of ethylene diamine N,N'-bis(ortho-hydroxyphenylacetic) acid and derivatives thereof | |
US3953605A (en) | Antimicrobial quaternary ammonium compounds compositions | |
US3721693A (en) | Metal halide-ester reaction process and compositions | |
KR100450007B1 (en) | Aqueous Synthesis of Iodopropargyl Carbamate | |
JPS6222752A (en) | Production of guazatine 3-alkylbenzenesulfonic acid salt | |
US2909535A (en) | Novel higher aliphatic acid derivatives and compositions containing the same | |
US4059687A (en) | Ester substituted dibiguanides and non-toxic antimicrobial compositions thereof | |
JP2714724B2 (en) | Cyclic amine compounds having a carboxyl group | |
US3251875A (en) | N-nitroso derivatives | |
GB1583363A (en) | Amphoteric fluorinated sulphonamides | |
US2655532A (en) | N-oxoalkyl-para-aminosalicylic acids | |
CA2162906A1 (en) | Preparation of n-cyanodithioimino-carbonates and 3-mercapto-5-amino-1h-1,2,4-triazole | |
WO2006034175A1 (en) | Synthesis process for 2-(3-hydroxy-1-adamantyl)-2-oxoacetic acid | |
US5981795A (en) | Method for the N-denitration of N-nitro-dinitroaniline in a homogeneous phase | |
US3052683A (en) | 4-phenyl-1-(2-phenylsulfinylethyl)-4-propionoxypiperidine and method for its preparation | |
JPH05508633A (en) | Intermediates used in the preparation of deferoxamine | |
JP2613857B2 (en) | Phosphobetaine | |
JP3503993B2 (en) | Method for producing N-mono-t-butyloxycarbonylalkylenediamine | |
JP3066466B2 (en) | Tris-tert-butoxy carbonate of trisphenol and composition containing the same | |
JP2939650B2 (en) | New sugar derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): JP KR |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: JP Ref document number: 1998539851 Format of ref document f/p: F |
|
122 | Ep: pct application non-entry in european phase |